IMTX logo

Immatics N.V. Ordinary Shares


IMTX: Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.


Show IMTX Financials

Consumer Interest
SEC Filings

Recent trades of IMTX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by IMTX's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of IMTX in WallStreetBets Daily Discussion


Recent insights relating to IMTX

CNBC Recommendations

Recent picks made for IMTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in IMTX

Corporate Flights

Flights by private jets registered to IMTX